Retroviral cell targeting vectors

Current Opinion in Molecular Therapeutics

Volumn 1, Issue 5, 1999, Pages 613-621

  Buchholz, Christian J ^a   Stitz, Joern ^a   Cichutek, Klaus ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Display libraries; MLV; Protease; Pseudotype; Retroviral vector; SNV

Indexed keywords

ENVELOPE PROTEIN; PROTEINASE; VIRUS VECTOR;

GENE TARGETING; GENE THERAPY; GENETICS; HUMAN; HUMAN CELL; MURINE LEUKEMIA VIRUS; PROTEIN ANALYSIS; PROTEIN MODIFICATION; RECEPTOR BINDING; RETROVIRUS; REVIEW; TISSUE SPECIFICITY;

GENE PRODUCTS, ENV; GENE TARGETING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROVIRIDAE;

EID: 0032692499     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Miller AD: Cell-surface receptors for retroviruses and implications for gene transfer. Proc Natl Acad Sci USA (1996) 93:11407-11413.
2. Weiss RA, Tailor CS: Retrovirus receptors. Cell (1995) 82(4):531-533.
3. Tailor CS, Nouri A, Lee CG, Kozak C, Kabat D: Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci USA (1999) 96(3):927-932.
4. Yang YL, Guo L, Xu S, Holland CA, Kitamura T, Hunter K, Cunningham JM: Receptors for polytropic and xenotropic mouse leukemia viruses encoded by a single gene at Rmc1. Nature Genet (1999) 21(2):216-219.
5. Rasko JE, Battini JL, Gottschalk RJ, Mazo I, Miller AD: The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc Natl Acad Sci USA (1999) 96(5):2129-2134.
6. Tailor CS, Willett BJ, Kabat D: A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J Virol (1999) 73:6500-6505.
7. Fass D, Harrison SC, Kim PS: Retrovirus envelope domain at 1.7 Angstrom resolution. Nature Struct Biol (1996) 3(5):465-469.
8. Fass D, Davey RA, Hamson CA, Kim PS, Cunningham JM, Berger JM: Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science (1997) 277(5332):1662-1666.
9. Hughson FM: Enveloped viruses: a common mode of membrane fusion? Curr Biol (1997) 7(9):R565-569.
10. Lavillette D, Maurice M, Roche C, Russell SJ, Sitbon M, Cosset FL: A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J Virol (1998) 72(12):9955-9965.
11. Wyatt R, Sodroski J: The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science (1998) 280(5371):1884-1888.
12. Chan DC, Kim PS: HIV entry and its inhibition. Cell (1998) 93(5):681-684.
13. Sakalian M, Hunter E: Molecular events in the assembly of retrovirus particles. Adv Exp Med Biol (1998) 440:329-339.
14. von Kalle C, Klem HP, Goehle S, Darovsky B, Heimfeld S, Torok-Storb B, Storb R, Schuening FG: Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood (1994) 84(9):2890-2897.
15. Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK: High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol (1995) 69(112):7430-7436.
16. Wilson C, Reitz MS, Okayama H, Eiden MV: Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus. J Virol (1989) 63(5):2374-2378.
17. Schnierie BS, Stitz J, Bosch V, Nocken F, Merget-Millitzer H, Engelstadter M, Kurth R, Groner B, Cichutek K: Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Natl Acad Sci USA (1997) 94(16):8640-8645.
18. Mammano F, Salvatori F, Indraccolo S, De Rossi A, Chieco-Bianchi L, Gottlinger HG: Truncation of the human Immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. J Virol (1997) 71(4):3341-3345.
19. Stitz J, Muller P, Merget-Millitzer H, Cichutek K: High-titer retroviral pseudotype vectors for specific targeting of human CD4-positive cells. Biogenic Amines (1998) 14:407-424.
20. Schnell MJ, Johnson JE, Buonocore L, Rose JK: Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell (1997) 90(5):849-857.
21. Mebatsion T, Finke S, Weiland F, Conzelmann KK: A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell (1997) 90(5):841-847.
22. Endres MJ, Jaffer S, Haggarty B, Turner JD, Doranz BJ, O'Brien PJ, Kolson DL, Hoxie JA: Targeting of HIV- and SIV-infected cells by CD4-chemokine receptor pseudotypes. Science (1997) 278(5342):1462-1464.
23. Balliet JW, Bates P: Efficient infection mediated by viral receptors incorporated into retroviral particles. J Virol (1998) 72(1):671-676.
24. Cosset F-L, Morling FJ, Takeuchi Y, Weiss RA, Collins MKL, Russell SJ: Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol (1995) 69(10):6314-6322.
25. Valsesia-Wittmann S, Morling FJ, Nilson BH, Takeuchi Y, Russell SJ, Cosset FL: Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU. J Virol (1996) 70(3):2059-2064.
26. Buchholz CJ, Peng KW, Morling FJ, Zhang J, Cosset FL, Russell SJ: In vivo selection of protease cleavage sites from retrovirus display libraries. Nature Biotechnol (1998) 16(10):951-954.
27. Zhao Y, Zhu L, Lee S, Ling L, Chang E, Soong NW, Douer D, Anderson WF: Identification of the block in targeted retroviral-mediated gene transfer. Proc Natl Acad Sci USA (1999) 96(7):4005-4010.
28. Buchholz CJ, Schneider U, Devaux P, Gerlier D, Cattaneo R: Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol (1996) 70(6):3716-3723.
29. Bae Y, Kingsman SM, Kingsman AJ: Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J Virol (1997) 71(3):2092-2099.
30. Zavorotinskaya T, Albritton LM: Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein. J Virol (1999) 73(6):5034-5042.
31. Battini JL, Danos O, Heard JM: Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. J Virol (1998) 72(1):428-435.
32. Kayman SC, Park H, Saxon M, Pinter A: The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system. J Virol (1999) 73(3):1802-1808.
33. Jiang A, Chu TH, Nocken F, Cichutek K, Domburg R: Cell-type specific gene transfer into human cells with retroviral vectors that display single-chain antibodies. J Virol (1998) 72(12):10148-10156.
34. Domburg R: From the natural evolution to the genetic manipulation of the host-range of retroviruses. Biol Chem (1997) 378(6):457-468.
35. Chu TH, Martinez I, Sheay WC, Domburg R: Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Ther (1994) 1(5):292-299.
36. Chu TH, Domburg R: Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J Virol (1995) 69(4):2659-2663.
37. Chu TH, Domburg R: Towards highly efficient cell-type-specific gene-transfer with retroviral vectors displaying single-chain antibodies. J Virol (1997) 71(1):720-725.
38. Kasahara N, Dozy AM, Kan YW: Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science (1994) 266(5189):1373-1376.
39. Han X, Kasahara N, Kan YW: Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci USA (1995) 92(21):9747-9751.
40. Kabat D: Targeting retroviral vectors to specific cells [letter]. Science (1995) 269(5222):417.
41. Cosset FL, Russell S J: Targeting retrovirus entry. Gene Ther (1996) 3(11):946-956.
42. Somia MV, Zoppe M, Verma IM: Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci USA (1995) 92(16):7570-7574.
43. Hall FL, Gordon EM, Wu L, Zhu NL, Skotzko MJ, Stames VA, Anderson WF: Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein. Hum Gene Ther (1997) 8(18):2183-2192.
44. Martin F, Kupsch J, Takeuchi Y, Russell S, Cosset FL, Collins M: Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope. Hum Gene Ther (1998) 9(5):737-746.
45. Fielding AK, Maurice M, Morling FJ, Cosset FL, Russell SJ: Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. Blood (1998) 91 (5):1802-1809.
46. Chadwick MP, Morting FJ, Cosset FL, Russell SJ: Modification of retroviral tropism by display of IGF-1. J Mol Biol (1999) 285(2):484-494.
47. Snitkovsky S, Young JA: Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein. Proc Natl Acad Sci USA (1998) 95(12):7063-7068.
48. Boerger AL, Snitkovsky S, Young JAT: Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proc Natl Acad Sci USA (1999) 96:9867-9872.
49. Nilson BH, Morling FJ, Russell SJ: Targeting of retroviral vectors through protease-substrate interactions. Gene Ther (1996) 3:280-286.
50. Peng KW, Morling FJ, Cosset FL, Murphy G, Russell SJ: A gene delivery system activatable by disease-associated matrix metalloproteinases. Hum Gene Ther (1997) 8:729-738.
51. Peng KW, Moiling FJ, Cosset FL, Murphy G, Russell SJ: A retroviral gene delivery system activatable by plasmin. Tumor Targeting (1998) 3:112-120.
52. Peng KW, Vile RG, Cosset FL, Russell SJ: Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors. Gene Ther (1999) 6:1552-1557.
53. Morling FJ, Peng KW, Cosset FL, Russell SJ: Masking of retroviral envelope functions by oligomerising polypeptide adaptors. Virology (1997) 234(1):51-61.
54. Schnierle BS, Moritz D, Jeschke M, Groner B: Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther (1996) 3(4):334-342.
55. Marin M, Noel D, Valsesia-Wittman S, Brockly F, Etienne-Julan M, Russell S, Cosset FL, Piechaczyk M: Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. J Virol (1996) 70(5):2957-2962.
56. Ager S, Nilson BH, Morling FJ, Peng KW, Cosset FL, Russell SJ: Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity. Hum Gene Ther (1996) 7(17):2157-2164.
57. Yajima T, Kanda T, Yoshiike K, Kitamura Y: Retroviral vector targeting human cells via c-Kit-stem cell factor interaction. Hum Gene Ther (1998) 9:779-787.
58. Benedict CA, Tun RYM, Rubinstein DB, Guillaume T, Cannon PM, Anderson WF: Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyse virus-cell fusion. Hum Gene Ther (1999) 10(4):545-557.